Ignite Creation Date:
2025-12-25 @ 4:04 AM
Ignite Modification Date:
2025-12-26 @ 2:58 AM
Study NCT ID:
NCT05662202
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-09-08
First Post:
2022-11-29
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Study to Evaluate the Safety, Tolerability and Efficacy of BF-200 ALA (Ameluz®) in the Field-directed Treatment of Actinic Keratosis (AK) on the Extremities and Neck/Trunk With Photodynamic Therapy (PDT) Using a RhodoLED Lamp
Sponsor:
Biofrontera Bioscience GmbH
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-12-12
Start Date Type:
ACTUAL
Primary Completion Date:
2025-09-03
Primary Completion Date Type:
ACTUAL
Completion Date:
2026-06
Completion Date Type:
ESTIMATED
First Submit Date:
2022-11-29
First Submit QC Date:
None
Study First Post Date:
2022-12-22
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-09-05
Last Update Post Date:
2025-09-08
Last Update Post Date Type:
ESTIMATED